Estimating the cost-effectiveness of pneumococcal conjugate vaccination in Brazil

Abstract

At the current vaccine price, conjugate vaccination could be a cost-effective investment compared to other options to control childhood diseases. Further analysis is required to determine whether vaccination at the current price is affordable to Brazil.